Delivery Order SPE2DP23D0001-SPE2D625F8M0E
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a $2,090.49 firm fixed-price delivery order (Contract No. 4568409126) to Canadian Commercial Corporation (CCC) on May 30, 2025, with an ultimate completion date of August 14, 2025. This delivery order, which carries no set-aside designation, represents a task order under CCC's existing contract vehicle and leverages the corporation's established government-to-government contracting relationship with U.S. defense agencies. CCC, a Crown...
- The U.S. Department of Defense's Medical Supply Chain awarded a $104.5K delivery order to Canadian Commercial Corporation (CCC) on October 2, 2025, for Reactive Skin Decontamination Lotion. This contract represents a firm fixed-price delivery order with an ultimate completion date of December 18, 2025, and carries no set-aside designation. The work will be performed in Ottawa, Ontario, Canada, reflecting CCC's role as a Crown corporation that serves as an intermediary facilitating...
- The U.S. Defense Department's Medical Supply Chain division awarded a delivery order valued at $8,361.96 to Canadian Commercial Corporation (CCC) on September 5, 2025, with an ultimate completion date of November 20, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a task order under CCC's broader relationship with U.S. defense procurement agencies. The work will be performed at CCC's facility in Ottawa, Ontario, Canada. As a Crown corporation and...
- The U.S. Defense Department's Medical Supply Chain division awarded a delivery order valued at $2,090.49 to Canadian Commercial Corporation (CCC) on August 30, 2025, with an ultimate completion date of November 14, 2025. This firm fixed-price contract represents a child order under a larger indefinite delivery vehicle and was not designated as a set-aside procurement. The work will be performed at CCC's facility located in Ottawa, Ontario, Canada. Canadian Commercial Corporation, a Crown...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $41,221.50 to Canadian Commercial Corporation (CCC) on October 2, 2025, for Inactive Skin Decontamination Lotion 21. This contract is a child delivery order under a larger indefinite delivery vehicle and utilizes firm fixed-price pricing with no set-aside designation. Performance will be completed by December 18, 2025, with work to be performed at CCC's facility in Ottawa, Ontario, Canada. The Reactive...
- The U.S. Department of Defense's Medical Supply Chain division awarded a delivery order valued at $2,090.49 to Canadian Commercial Corporation (CCC) on September 10, 2025, with an ultimate completion date of November 25, 2025. This firm fixed-price delivery order represents a child contract under CCC's existing relationship with U.S. federal defense agencies. The contract involves no set-aside designation, reflecting CCC's government-to-government contracting model as a Crown corporation owned...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,090.49 firm fixed-price delivery order to Canadian Commercial Corporation (CCC) on September 26, 2025, with completion scheduled for December 12, 2025. This delivery order, issued under contract number 4569620763, represents a non-set-aside procurement utilizing CCC's established government-to-government contracting relationship with U.S. federal agencies. The work will be performed at CCC's facility in Ottawa, Ontario, Canada....
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to Canadian Commercial Corporation (CCC) on October 2, 2025, for the supply of Inactive Skin Decontamination Lotion 21. This contract, valued at $1,648.86, is a firm fixed-price delivery order with an ultimate completion date of December 18, 2025. The contract carries no set-aside designation, reflecting CCC's role as a Crown corporation facilitating government-to-government contracting between U.S. federal agencies and...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to Canadian Commercial Corporation (CCC) on October 2, 2025, for Inactive Skin Decontamination Lotion 21. This contract, valued at $1,099.24 with a firm fixed price structure, represents a child delivery order with an ultimate completion date of December 18, 2025. The work will be performed at CCC's facility located in Ottawa, Ontario, Canada. No set-aside designation was utilized for this procurement, consistent with...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $2,090.49 to Canadian Commercial Corporation (CCC) on July 10, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price contract, issued without set-aside designation, represents a task order under CCC's broader relationship as a prime contractor facilitating government-to-government procurement between U.S. defense agencies and Canadian suppliers. The work will be performed at CCC's...
- SPE2DP23D0001Indefinite Delivery Contract
- SPE2DP23D0001-SPE2D625F8M0EDelivery Order
The Defense Department's Medical Supply Chain division awarded a $2,090.49 firm fixed-price delivery order to Canadian Commercial Corporation (CCC) on May 20, 2025, with an ultimate completion date of August 5, 2025. This delivery order, contract number 4568321059, represents a child contract with no set-aside designation and will be performed in Ottawa, Ontario, Canada. CCC, a Crown corporation that serves as an intermediary facilitating government-to-government contracting between U.S. federal agencies and Canadian exporters, is well-positioned to deliver defense-related medical supplies through its established capabilities and strategic partnerships with the Defense Logistics Agency and other military procurement entities. The contract includes a subcontract awarded to Emergent Biosolutions Canada Inc. on May 21, 2025, for the provision of Reactive Skin Decontamination Lotion. Emergent Biosolutions specializes in medical countermeasures against chemical, biological, radiological, and nuclear threats and has extensive experience supplying this decontamination product to U.S. defense agencies. This delivery order exemplifies the collaborative procurement approach between U.S. defense logistics and Canadian manufacturing capabilities for specialized medical supplies critical to military readiness and personnel protection.
ContractNumber | Description | Subcontractor | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
105929621S | Emergent Biosolutions Canada Inc. | Delivery Order SPE2DP23D0001-SPE2D625F8M0E | $0 | 5/21/25 |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 5/20/25 |